🔎 Trials Near Me

Utama › Karsinoma Sel Skuamosa Kepala dan Leher › Texas › Dallas

Kajian klinikal Karsinoma Sel Skuamosa Kepala dan Leher di Dallas, TX

20 kajian untuk Karsinoma Sel Skuamosa Kepala dan Leher sedang mencari peserta di lokasi dalam dan sekitar Dallas (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Mengambil pesertaFasa 1
  • Exelixis Clinical Site #89, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05176483

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

Mengambil pesertaFasa 3
  • UT Southwestern Medical Center, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07276399

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Mengambil pesertaFasa 1/2
  • Baylor, Scott and White Research Institute, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06047379

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Mengambil pesertaKajian pemerhatian
  • UT Southwestern Medical Center, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT05059444

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Mengambil pesertaFasa 1
  • Normunity Investigational Site, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT07182149

A Study of DM005 in Patients With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • Sarah Cannon Research Institute at Mary Crowley, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT06515990

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Mengambil pesertaFasa 1/2
  • Texas Oncology, P.A., Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Ogo 2026 · NCT06330064

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • Texas Oncology, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jul 2026 · NCT03526835

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Mengambil pesertaFasa 1
  • University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
  • UT Southwestern Medical Center - Redbird, Dallas
  • Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital, Dallas
  • dan 2 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Jul 2026 · NCT05208762

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
  • University of Texas Southwestern, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT05768139

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Mengambil pesertaFasa 1
  • University of Texas Southwestern Medical Center /ID# 251974, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Jun 2026 · NCT04777994

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

Mengambil pesertaFasa 3
  • GSK Investigational Site, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Mei 2026 · NCT06256588

A Study of VET3-TGI in Patients With Solid Tumors

Mengambil pesertaFasa 1
  • Mary Crowley Cancer Research, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Apr 2026 · NCT06444815

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 1/2
  • NEXT Oncology - Dallas, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Feb 2026 · NCT07030257

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Mengambil pesertaFasa 1
  • Mary Crowley Cancer Research, Dallas
  • Baylor University Medical Center, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Feb 2026 · NCT06778863

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Mengambil pesertaFasa 1
  • Dren Investigational Site, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jan 2026 · NCT06999187

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Mengambil pesertaFasa 1/2
  • Research Site 120, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Nov 2025 · NCT05914116

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 1/2
  • Mary Crowley Cancer Research, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Okt 2025 · NCT04370587

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • Mary Crowley Cancer Research, Dallas
  • University of Texas Southwestern Medical Center, Dallas
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2025 · NCT05941507

Kajian Karsinoma Sel Skuamosa Kepala dan Leher di bandar lain

Kajian lain di Dallas

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.